New medications for Alzheimer’s disease

scientists – long for hero page

CCNA is accelerating progress in dementia research

CCNA provides the infrastructure and support that facilitates collaboration amongst Canada’s dementia researchers and clinicians.

What is CCNA’s mission

The Canadian Consortium on Neurodegeneration in Aging (CCNA) provides the infrastructure and support that facilitates collaboration amongst Canada’s top dementia researchers and clinicians. CCNA is the premier hub for Alzheimer’s disease and dementia research in Canada, and a global leader in research on all aspects of neurodegenerative diseases from prevention to treatment to improving the quality of life of those living with the disease.

Brain showing colorful neurons

Read our news

This is where we share all news, milestones, people we celebrate, and CCNA projects and activities.

  • November 14, 2025

    Pamela Roach receives the Killam Emerging Research Leader Award at the University of Calgary

  • October 29, 2025

    Dr. Chertkow interview with the CBC

  • October 22, 2025

    CCNA annual conference 2025 – trainee poster award winners

Partner organizations

More than a financial investment, CCNA’s Partner Organizations share the vision of leading in the prevention, treatment, and management of the neurodegenerative diseases of aging. CCNA is a Government of Canada initiative, also supported by several national, provincial and nonprofit organizations.

Illustration of elderly people on a park bench
CCNA - CCNV logo

Get the latest news

Keep up to date with the latest research developments at CCNA. Our “News” section provides information on studies, new developments and key findings in brain health research.